Cistron Biotechnology(CIST)$.30 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: thomas larkin who wrote (1280)	7/20/1998 12:19:00 AM
From: Steve Harmon	Read Replies (1) of 2742

Bluestone Capital, Cistron's cash position is 55 cents a share. The Rhone Poulenc deal gives IL-1 a potential minimum value of $31 million or $1.35 a share>>>>> Cistron's assets>.55 + 1.35= $1.90 Current market value= .32 Why are shareholder assets now trading at 1/6th of their value? Why does IL-1 still have a market value of ZERO? Nasdaq experts???

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next